Abstract: Eighteen
Gag mutations showed a significantly higher prevalence in
PI/r-treated isolates compared to ART-naive (p < 0.05): Group 1 (prevalence < 1% in drug-naive):
L449F,
D480N,
L483Q,
Y484P,
T487V; group 2 (prevalence 1-5% in drug-naive):
S462L,
I479G,
I479K,
D480E; group 3 (prevalence >= 5% in drug-naive):
P453L,
E460A,
R464G,
S465F,
V467E,
Q474P,
I479R, <